Home | Non-food | Drug

Drug

FDA approves first combination pill to treat hepatitis C

FDA News Release FDA approves first combination pill to treat hepatitis C For Immediate Release October 10, 2014 Release The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and
Full story

FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy

FDA News Release FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy For Immediate Release October 10, 2014 Release The U.S. Food and Drug Administration today approved Akynzeo ...
Full story

Caring for Pierced Ears: Tips from Dermatologists

  SCHAUMBURG, Ill. (October 7, 2014) – Although ear piercings are more common and can be less risky than other body piercings, they can still cause complications if ...
Full story

Heroin overdose deaths increased in many states through 2012

Press Release Embargoed until: Thursday, October 2, 2014, 1:00 Noon, ETContact: CDC Media Relations (404) 639-3286 Heroin overdose deaths increased in many states through 2012Still twice as many people died ...
Full story

3D Technologies Poised to Change How Doctors Diagnose Cancers

Breast cancer in 3D Red envelope icon for Govdelivery Get Consumer Updates by E-mail RSS feed orange symbol Consumer Updates RSS Feed pdf icon small Print & Share ...
Full story

Xolair (omalizumab): Drug Safety Communication - Slightly Elevated Risk of Cardiovascular and Cerebrovascular Serious Adverse Events

Xolair (omalizumab): Drug Safety Communication - Slightly Elevated Risk of Cardiovascular and Cerebrovascular Serious Adverse Events AUDIENCE: Allergy and Immunology, Pharmacy, Health Professional ISSUE: An FDA review ...
Full story

FDA warns consumers not to use Eu Yan Sang (Hong Kong) Ltd.’s “Bo Ying compound"

The U.S. Food and Drug Administration warns parents and caregivers not to use “Bo Ying compound” manufactured by Eu Yan Sang (Hong Kong) Ltd. due ...
Full story

Double mastectomy no better than conservative breast surgery plus radiation

Thursday Sep 25, 2014 (foodconsumer.org) --- A new study published in JAMA suggests that double mastectomy provides no extra benefit compared with breast-conserving surgery plus ...
Full story

HIV/AIDS Update - Approval of Tybost (cobicistat) 150 mg tablets

On September 24, 2014, FDA approved Tybost (cobicistat) 150 mg tablets. Tybost is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir ...
Full story

HIV/AIDS Update - Approval of Vitekta

On September 24, 2014, FDA approved Vitekta (elvitegravir) 85 mg and 150 mg tablets. Vitekta is a human immunodeficiency virus type 1 (HIV-1) integrase strand ...
Full story